Cabozantinib
Back to search| Scientific Name: | Cabozantinib |
| Brand Name: | Cabometyx, Cometriq |
| Company Owner: | Not Available |
| Mechanism Of Action | Cabozantinib inhibits specific receptor tyrosine kinases such as VEGFR-1, -2 and -3, KIT, TRKB, FLT-3, AXL, RET, MET, and TIE-2. |
| Description of the Drug: | Cabozantinib is a tyrosine kinase inhibitor used to treat advanced renal cell carcinoma, hepatocellular carcinoma, and medullary thyroid cancer. |
| Protein Data Bank: | Not Available |
Source: DrugBank Online – DrugBank.com. Retrieved 2023-01-23 from https://go.drugbank.com/drugs/DB08875
